Plain-English translation of NCT05699655 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing whether a medication called , when combined with two other drugs ( and standard chemotherapy), works better than chemotherapy alone for advanced stomach cancer. Doctors give this treatment before surgery to try to shrink the cancer and make surgery more successful. The study will compare how well the new combination works against the standard treatment.
Advanced stomach cancer is very difficult to treat, and surgery alone often isn't enough to cure it. Researchers hope that adding immunotherapy—a type of treatment that helps your body's immune system fight cancer—to standard chemotherapy before surgery might help more patients survive longer and have better outcomes.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will be randomly assigned to receive either the new combination treatment with immunotherapy or standard chemotherapy alone. Both groups receive treatment before surgery to shrink the cancer. You will have regular doctor visits, blood tests, and imaging scans to monitor how well the treatment is working and to check for side effects. After treatment is complete, you will have surgery to remove the cancer.
AI-generated summary from trial data · Jul 6, 2026 · Not medical advice
China